DXCM241206C95000
- 0.05
- 0.000.00%
DexCom Newsroom
Morgan Stanley Maintains Positive MedTech Outlook Despite Setbacks in 2024, Upgrades Intuitive Surgical And Stryker, Downgrades Nevro And Glaukos
December Starts With a Mixed Market | Live Stock
3 Reasons to Buy DexCom Stock Like There's No Tomorrow
The Return Trends At DexCom (NASDAQ:DXCM) Look Promising
Is DexCom, Inc. (NASDAQ:DXCM) Potentially Undervalued?
Wednesday Ends With Index Decline | Wall Street Today
Dow Hits Another Record, Core PCE 2.8% as Expected | Live Stock
Why Is DexCom, Inc. (DXCM) Among the Worst Performing Healthcare Stocks in 2024?
S&P 500, Dow Hit Records, Trump Tariffs to Cost Hundreds of Billions | Wall Street Today
Dow Falls After Record, Trump Talks Tariffs on Day One | Live Stock
DexCom, Inc. (DXCM): Innovation and Growth Catalysts Amid Strong Long-Term Outlook for Diabetes Care
BofA Securities Maintains DexCom(DXCM.US) With Buy Rating
Australia Diabetes Market Forecasts and Company Analysis 2024-2032, Novo Nordisk, Eli Lilly, Roche, Abbott Laboratories, Insuletn, Dexcom, Medtronic, Ypsomed
S&P 500, Dow Hit Records Right After Open | Live Stock
Bank of America Securities Reaffirms Their Buy Rating on Dexcom (DXCM)
Express News | Dexcom Inc : Leerink Partners Cuts Target Price to $86 From $87
Weekly Buzz: Nvidia Falls on Near Perfect Report, but Only For a Day
Market Climbs, Bitcoin Close to $100k | Live Stock
Here's Why DexCom (DXCM) Declined In Q3
DexCom and OURA Ink Partnership for Metabolic Health Innovation